[18F]DPA-714 is currently under investigation as a potential radiopharmaceutical for imaging TSPO in living systems using positron emision tomography (PET).
The 18 kDa translocator protein (TSPO) is an ideal target for neuroinflammation imaging.
Interested in our products?
Contact us to discuss the possibilities.